To get full control of C-CAR031, AZ is buying out AbelZeta's 50% share of the China development and commercialisation rights ...

Real-world evidence highlights the effectiveness of teclistamab and elranatamab in treating frail multiple myeloma patients, paving the way for future therapies.

Explore the complexities of modern oncology, including precision medicine, CAR T-cell therapies, and challenges in breast ...

Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine — which designs ...

All patients with autoimmune hemolytic anemia in a small study initially achieved remission, though two eventually relapsed, ...